TABLE 11: Treatment - surgery

% of Cases treated with Surgery
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 47.8% 43.7% 49.0% 39.7% - 42.3%
All xnmsc 0-24 49.4% 48.2% 49.6% 49.8% - 45.1%
All xnmsc 25-59 65.1% 62.8% 65.8% 59.9% - 62.6%
All xnmsc 60-79 47.6% 42.9% 49.0% 38.3% - 41.5%
All xnmsc 80+ 29.7% 25.8% 30.8% 20.5% - 26.0%
Haematology 5.9% 5.0% 6.1% 4.4% - 4.6%
Head and Neck 53.1% 47.0% 55.3% 40.6% - 45.2%
Lower GI 65.6% 62.7% 66.6% 58.8% - 62.9%
Upper GI 34.2% 23.9% 37.4% 15.7% - 18.7%
HPB 31.4% 21.9% 34.2% 10.8% - 20.6%
Trachea, Bronchus & Lung 26.6% 19.8% 29.1% 13.0% - 17.2%
Melanoma of skin 96.8% 97.1% 96.6% 97.8% - 97.0%
Breast 75.4% 75.8% 75.3% 75.7% - 76.3%
Cervix 60.7% 53.9% 62.8% 49.6% - 49.4%
Other Female Genitals 74.9% 72.2% 75.8% 67.5% - 73.2%
Prostate 22.2% 16.5% 23.7% 11.0% - 14.7%
Kidney 57.2% 52.4% 58.7% 47.6% - 51.0%
Bladder 85.8% 84.7% 86.1% 82.5% - 85.3%
Brain and CNS 48.4% 43.8% 49.4% 46.7% - 35.2%
Thyroid & other endocrine glands 87.1% 82.3% 88.4% 76.8% - 81.6%
CUP 12.0% 8.7% 13.1% 3.4% - 9.6%
Other invasive cancer 56.7% 51.8% 58.1% 45.8% - 51.5%
Breast in situ 85.6% 87.2% 85.2% 92.3% - 84.2%
Cervix in situ 89.6% 85.8% 89.8% 98.1% - 69.6%
Other tumours 63.7% 65.1% 62.6% 71.8% - 60.7%
Non-Melanoma Skin Cancer 50.2% 58.4% 47.3% 91.7% - 36.1%